Evidence map›Paper›PMID 38671154›Full record

ArticleNature biotechnology2025

Analysis and benchmarking of small and large genomic variants across tandem repeats.

Adam C English, Egor Dolzhenko, Helyaneh Ziaei Jam, Sean K McKenzie, Nathan D Olson, Wouter De Coster, Jonghun Park, Bida Gu, Justin Wagner, Michael A Eberle and 4 more

Open access · greenAbstract read
In one paragraph

Article in Nature biotechnology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 63 papers.

0numbers the graph read from it
0cells of the map it votes in
63citing papers in PubMed
14.0field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

63 citing papers in PubMed, 61 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

3 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

14 authors at 6 institutions in 2 countries.

Adam C EnglishHuman Genome Sequencing Center, Baylor College of Medicine, Houston, TX, USA. adam.english@bcm.edu.ORCID http://orcid.org/0000-0003-2451-4375
Egor DolzhenkoPacific Biosciences of California, Menlo Park, CA, USA.ORCID http://orcid.org/0000-0002-3296-0677
Helyaneh Ziaei JamDepartment of Computer Science and Engineering, University of California, San Diego, La Jolla, CA, USA.
Sean K McKenzieOxford Nanopore Technologies, Inc., New York, NY, USA.
Nathan D OlsonMaterial Measurement Laboratory, National Institute of Standards and Technology, Gaithersburg, MD, USA.ORCID http://orcid.org/0000-0003-2585-3037
Wouter De CosterApplied and Translational Neurogenomics Group, VIB Center for Molecular Neurology, VIB, Antwerp, Belgium.ORCID http://orcid.org/0000-0002-5248-8197
Jonghun ParkDepartment of Computer Science and Engineering, University of California, San Diego, La Jolla, CA, USA.
Bida GuDepartment of Quantitative and Computational Biology, University of Southern California, Los Angeles, CA, USA.ORCID http://orcid.org/0000-0001-8575-997X
Justin WagnerMaterial Measurement Laboratory, National Institute of Standards and Technology, Gaithersburg, MD, USA.
Michael A EberlePacific Biosciences of California, Menlo Park, CA, USA.
Melissa GymrekDepartment of Computer Science and Engineering, University of California, San Diego, La Jolla, CA, USA.
Mark J P ChaissonDepartment of Quantitative and Computational Biology, University of Southern California, Los Angeles, CA, USA.ORCID http://orcid.org/0000-0001-5395-1457
Justin M Zook *Material Measurement Laboratory, National Institute of Standards and Technology, Gaithersburg, MD, USA.
Fritz J Sedlazeck *Human Genome Sequencing Center, Baylor College of Medicine, Houston, TX, USA. fritz.sedlazeck@bcm.edu.ORCID http://orcid.org/0000-0001-6040-2691
National Institute of Standards and Technology · USUniversity of California San Diego · USBaylor College of Medicine · USPacific Biosciences (United States) · USUniversity of Southern California · USUniversity of Antwerp · BE

Funding

South Texas Alzheimer's Disease Research CenterP30AG066546 · NIA · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · PI Sudha Seshadri · 2021 to 2026
$24.0M
Identifying and Characterizing the Full Spectrum of Haplotype-resolved Structural Variation in Human GenomesU24HG007497 · NHGRI · UNIVERSITY OF CONNECTICUT SCH OF MED/DNT · PI Evan Eichler, CHARLES LEE · 2019 to 2026
$17.2M
Frequency of variants of unknown significance by ancestry groups in the All of Us Research Program cohortU01HG011758 · NHGRI · BAYLOR COLLEGE OF MEDICINE · PI RICHARD A GIBBS, JAMES R. LUPSKI · 2021 to 2026
$13.8M
Therapeutic target discovery in ADSP data via comprehensive whole-genome analysis incorporating ethnic diversity and systems approachesU01AG058589 · NIA · BOSTON UNIVERSITY MEDICAL CAMPUS · PI BOERWINKLE, ERIC A., DE JAGER, PHILIP L · 2018 to 2022
$11.1M
Refining Mendelian disease analysis via detection of clinically relevant repeat variantsR01HG010149 · NHGRI · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI Vineet Bafna, Vikas Bansal · 2018 to 2026
$4.5M
Detection and genotyping complex human genetic variation using single-molecule sequencingR01HG011649 · NHGRI · UNIVERSITY OF SOUTHERN CALIFORNIA · PI Mark Chaisson · 2021 to 2026
$2.5M
Identification of somatic/ mosaic SV and transposon activity and their crosstalk to DNA epigenetic ModificationsUG3NS132105 · NINDS · BAYLOR COLLEGE OF MEDICINE · PI SEDLAZECK, FRITZ J, WU, TAO · 2023 to 2024
$580k
NHGRI NIH HHS R01 HG010149NHGRI NIH HHS R01 HG011649NHGRI NIH HHS U01 HG011758NHGRI NIH HHS U24 HG007497NIA NIH HHS P30 AG066546NIA NIH HHS U01 AG058589NINDS NIH HHS UG3 NS132105
6 · The paper itself

Abstract

Tandem repeats (TRs) are highly polymorphic in the human genome, have thousands of associated molecular traits and are linked to over 60 disease phenotypes. However, they are often excluded from at-scale studies because of challenges with variant calling and representation, as well as a lack of a genome-wide standard. Here, to promote the development of TR methods, we created a catalog of TR regions and explored TR properties across 86 haplotype-resolved long-read human assemblies. We curated variants from the Genome in a Bottle (GIAB) HG002 individual to create a TR dataset to benchmark existing and future TR analysis methods. We also present an improved variant comparison method that handles variants greater than 4 bp in length and varying allelic representation. The 8.1% of the genome covered by the TR catalog holds ~24.9% of variants per individual, including 124,728 small and 17,988 large variants for the GIAB HG002 'truth-set' TR benchmark. We demonstrate the utility of this pipeline across short-read and long-read technologies.

Indexed as

Genetic VariationGenome, HumanGenomicsTandem Repeat SequencesBenchmarkingHaplotypesHumans

Identifiers

PMID38671154
PMCPMC11952744
OpenAlexW4395667653

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.